Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

…, M Yang, M Cao, H Zheng, W Wu, R Zou… - Journal of Allergy and …, 2020 - Elsevier
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …

Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)

…, P Yi, C Ding, W Wu, Y Li, Q Ni, R Zou… - Clinical infectious …, 2020 - academic.oup.com
Background An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public
health emergency. Data are limited on the duration and host factors related to viral shedding. …

Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome

…, L Xing, L Peng, J Wei, M Cao, H Zheng, W Wu, R Zou… - MedRxiv, 2020 - medrxiv.org
The outbreak of Coronavirus Disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019, and …

[PDF][PDF] Genesis, evolution and prevalence of H5N6 avian influenza viruses in China

…, J Liu, J Wu, R Yin, L Zhao, M Li, Z Ding, R Zou… - Cell host & …, 2016 - cell.com
Constant surveillance of live poultry markets (LPMs) is currently the best way to predict and
identify emerging avian influenza viruses (AIVs) that pose a potential threat to public health. …

[HTML][HTML] Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study

…, MJ Deen, Y Li, L Qing, Y Zhang, C Chen, R Zou… - Respiratory …, 2021 - Springer
Background Thousands of Coronavirus Disease 2019 (COVID-19) patients have been
discharged from hospitals Persistent follow-up studies are required to evaluate the prevalence of …

[HTML][HTML] Antiviral efficacy and safety of molnupiravir against omicron variant infection: a randomized controlled clinical trial

R Zou, L Peng, D Shu, L Zhao, J Lan, G Tan… - Frontiers in …, 2022 - frontiersin.org
Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed
a new wave of COVID-19 outbreaks. The efficacy of molnupiravir, an approved drug, is …

Clinical and immunological characteristics of human infections with H5N6 avian influenza virus

…, H Li, H Li, W Xu, W Shi, C Quan, R Zou… - Clinical Infectious …, 2019 - academic.oup.com
Background H5N6 avian influenza virus (AIV) has caused sporadic, recurring outbreaks in
China and Southeast Asia since 2013, with 19 human infections and 13 deaths. Seventeen of …

Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of hepatitis B virus

…, J Yuan, J Lu, H Li, W Zeng, Y Deng, R Zou… - Hepatology …, 2016 - Wiley Online Library
Aim We aimed to investigate the efficacy and safety of telbivudine (LdT) on the intervention
of mother‐to‐child transmission (MTCT) in different trimesters of pregnant women with high …

Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation

WJ Liu, J Li, R Zou, J Pan, T Jin, L Li… - Proceedings of the …, 2020 - National Acad Sciences
Avian-origin influenza viruses overcome the bottleneck of the interspecies barrier and infect
humans through the evolution of variants toward more efficient replication in mammals. The …

[HTML][HTML] Effect of corticosteroid therapy on the duration of SARS-CoV-2 clearance in patients with mild COVID-19: a retrospective cohort study

…, X Feng, Y Chen, J Yuan, P Yi, Y Li, Q Ni, R Zou… - Infectious diseases and …, 2020 - Springer
Introduction In December, 2019, an outbreak of the coronavirus disease 2019 (COVID-19),
which was caused by a novel coronavirus, started in Wuhan, China. So far, there is limited …